)
)
Repare Therapeutics Investor Relations Material
Latest events
Study Update
Repare Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Repare Therapeutics Inc
Access all reports
Repare Therapeutics Inc. (RPTX) is a clinical-stage precision oncology company focused on the development of novel therapeutics using its synthetic lethality approach. The company leverages its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop cancer therapies aimed at genomic instability, including DNA damage repair.
Key slides for Repare Therapeutics Inc
Study Update
Repare Therapeutics Inc
Study Update
Repare Therapeutics Inc
Latest articles
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Ticker symbol
RPTX
Country
🇺🇸 United States